Login / Signup

Factors related to inappropriate edoxaban use.

Bo Min JangOk Sang LeeEun Jeong ShinEun Jeong ChoSung Yeon SuhYoon Sook ChoMyung Koo LeeSandy Jeong Yeon Rhie
Published in: Journal of clinical pharmacy and therapeutics (2019)
Although edoxaban has a broad therapeutic window that does not require routine monitoring, it should be cautiously used in patients with renal insufficiency (CrCl <50 mL/min) and body weight <60 kg.
Keyphrases
  • body weight
  • venous thromboembolism
  • clinical practice